Search Results - "Ongagna, J.C."

Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients by Martinot, M., Eyriey, M., Gravier, S., Bonijoly, T., Kayser, D., Ion, C., Mohseni-Zadeh, M., Camara, S., Dubois, J., Haerrel, E., Drouaine, J., Kaiser, J., Ongagna, J.C., Schieber-Pachart, A., Kempf, C.

“…•In March 2020, 25% of patients with COVID-19 were admitted to the intensive care unit (ICU) and 19% died.•The main clinical factors associated with death were…”
Get full text

Clinical features and outcomes in adults with COVID-19 during the pre-Omicron and Omicron waves by Martinot, M., Schieber, A., Ongagna, J.C., Henric, A., Eyriey, M., Mohseni-Zadeh, M., Ion, C., demesmay, K, Gravier, S., Kempf, C.

“…•The death rate for Omicron inpatients (n = 1142) was 11 % vs 16.9 % for pre-Omicron inpatients (n = 1690)•Independent risk factors for death included…”
Get full text

Evolution of baseline characteristics and severe outcomes in COVID-19 inpatients during the first and second waves in Northeastern France by Martinot, M., Eyriey, M., Gravier, S., Kayser, D., Ion, C., Mohseni-Zadeh, M., Ongagna, J.C., Schieber, A., Kempf, C.

“…•Patients hospitalized with COVID-19 during the second wave of the epidemics were associated with a shorter time between symptom onset and hospitalization,…”
Get full text

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort by Outteryck, O., Ongagna, J.C., Brochet, B., Rumbach, L., Lebrun-Frenay, C., Debouverie, M., Zéphir, H., Ouallet, J.C., Berger, E., Cohen, M., Pittion, S., Laplaud, D., Wiertlewski, S., Cabre, P., Pelletier, J., Rico, A., Defer, G., Derache, N., Camu, W., Thouvenot, E., Moreau, T., Fromont, A., Tourbah, A., Labauge, P., Castelnovo, G., Clavelou, P., Casez, O., Hautecoeur, P., Papeix, C., Lubetzki, C., Fontaine, B., Couturier, N., Bohossian, N., Clanet, M., Vermersch, P., de Sèze, J., Brassat, D.

“…Background and purpose BIONAT is a French multicentric phase IV study of natalizumab (NTZ)‐treated relapsing−remitting multiple sclerosis (MS) patients. The…”
Get full text

Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetes by Ongagna, J.C., Pinget, M., Belcourt, A.

“…Vitamin D-binding protein (DBP) is the main systemic transporter of 1.25(OH) 2D 3 and is essential for its cellular endocytosis. There are two known…”
Get full text

Difficultés ressenties au travail par les patients atteints de sclérose en plaques by Ongagna, J.C., Passadori, A., Pinelli, J., Isner-Horobeti, M.E., Zaenker, C., De Seze, J.

“…La sclérose en plaques (SEP) est une maladie du système nerveux central qui affecte le jeune adulte à une période où il se lance dans la vie active. Le…”
Get full text

The HLA-DQB alleles and amino acid variants of the vitamin D-binding protein in diabetic patients in Alsace by Ongagna, J.C, Kaltenbacher, M.C, Sapin, R, Pinget, M, Belcourt, A

“…Background: The HLA-DQB1 chain, in particular the amino acid in position 57, and genetic variants of the vitamin D-binding protein (DBP) have been reported to…”
Get full text

Sensibilité diagnostique des trousses Cis bio International pour la détection des autoanticorps anti-GAD65 et anti-IA-2 marqueurs de prédiction du diabète de type 1 chez les sujets à risque by Ongagna, J.C., Sapin, R, Pinjet, M, Grucker, D

“…Les autoanticorps anti-îlots de Langerhans (ICA), marqueurs de référence pour le diabète de type 1, sont détectés chez environ 85 % de patients au moment du…”
Get full text